Company: BWMN
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001193125-25-087211
Chunk: 23

Company: Bowman Consulting Group Ltd.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 23
---
itz, Hickey and Bruen, the grant date fair value of restricted stock awards granted under the Long-Term Incentive Plan in February 2024 calculated in accordance with ASC Topic 718, based on the grant date of February 8, 2024, in the following amounts: Mr. Labovitz—$111,070; Mr. Hickey—$107,082 and Mr. Bruen—$111,070. The restricted stock awards vest over a three-year period beginning one year from the date of grant. |

| iii. | For Messrs. Bowman, Hickey and Bruen, the grant date fair value of restricted stock awards granted in February 2025 under the Annual Bonus Plan calculated in accordance with ASC Topic 718, in the following amounts: Mr. Bowman—$114,314; Mr. Hickey—$21,944; and Mr. Bruen—$75,912. The annual incentive award is paid to each executive officer under the Annual Bonus Plan based on the Company’s level of achievement of performance objectives during each fiscal year. Under the Annual Plan, the annual bonus may be paid in cash, stock, or a combination of stock and cash based on the determination of the compensation committee, with recommendations from the Chief Executive Officer regarding the form of payment for each executive. The restricted stock awards vest no later than the first trading day of the calendar year following the date of the award. The compensation committee determined that Messrs. Bowman and Bruen would receive payment of the entire award in restricted stock, Mr. Labovitz would receive payment of the entire award in cash, and Mr. Hickey would receive 30% of the annual bonus in the form of restricted stock and 70% of the annual award in cash. See “Annual Bonus Plan” and footnote 5 below. |

| Page | 18 |     | 2025 Proxy Statement |

| iv. | For Mr. Labovitz the grant date fair value of performance-based restricted stock units granted in July 2024 for the performance period July 1, 2024, through June 30, 2028, based on the original grant date of July 1, 2024. The grant date fair value of the performance-based restricted stock units was $2,294,000, computed based on the probable outcome of the performance target as of the grant date which was the maximum (or highest) level of achievement of the performance target. In addition, this includes for Mr. Lab